熱門資訊> 正文
MaxCyte任命Parmeet Ahuja为首席财务官
2026-03-23 20:27
- MaxCyte (MXCT) said on Monday that it appointed Parmeet Ahuja as CFO, effective March 30, 2026, succeeding Douglas Swirsky, who is stepping down as previously announced.
- Ahuja brings over 20 years of finance leadership experience and most recently served as vice president of investor relations at Agilent Technologies.
- Shares +1.69%.
More on MaxCyte
- Quant snapshot: AAR, Noah Holdings lead strong buys as Blaize, Fractyl Health lag
- MaxCyte sees Q4 core revenue between $6.6M and $6.7M
- Seeking Alpha’s Quant Rating on MaxCyte
- Historical earnings data for MaxCyte
- Financial information for MaxCyte
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。